Vaxcyte, Inc.
corporate_fare Company Profile
Vaxcyte, Inc. (NASDAQ:PCVX) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 27 items for PCVX at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- Vaxcyte Establishes New $500M At-The-Market Offering Program, Replacing Prior Agreement
- Vaxcyte Files Prospectus for New $500M At-The-Market Offering Program
- Vaxcyte Accelerates VAX-31 into Multiple Phase 3 Trials, Secures Long-Term Manufacturing, and Finalizes $600M Offering
- Vaxcyte Reports Strong Cash Position and Significant Clinical Progress for VAX-31 Programs
- Vaxcyte Finalizes $600.2M Public Offering with Full Over-Allotment Exercise
Financial Snapshot
Fiscal year ended December 31, 2025
Net Income
-$766.63M
Diluted EPS
-$5.63
Op. Cash Flow
-$655.58M
Free Cash Flow
-$669.29M
Operating Income
-$923.67M
Cash & Equivalents
$173.96M
Debt / Equity
0.00×
Shares Outstanding
131.06M sh
Source: 10-K · filed 2026-02-24 · accession 0001649094-26-000007
show_chartPrice Chart
Loading chart...
feed PCVX - Filings & News (Page 2)
PCVX
Feb 24, 2026, 5:21 PM EST
Price at Filing:
$59.16
Real-time Price:
$55.72
Change:
-$3.44 (-6%)
Market Cap:
$8.768B
PCVX
Feb 24, 2026, 5:19 PM EST
Price at Filing:
$59.16
Real-time Price:
$55.72
Change:
-$3.44 (-6%)
Market Cap:
$8.768B
PCVX
Feb 24, 2026, 4:37 PM EST
Price at Filing:
$59.16
Real-time Price:
$55.72
Change:
-$3.44 (-6%)
Market Cap:
$8.768B
PCVX
Feb 24, 2026, 4:14 PM EST
Price at Filing:
$61.35
Real-time Price:
$55.72
Change:
-$5.63 (-9%)
Market Cap:
$8.768B
PCVX
Feb 02, 2026, 4:01 PM EST
Price at Filing:
$57.40
Real-time Price:
$55.72
Change:
-$1.68 (-3%)
Market Cap:
$8.768B
PCVX
Jan 30, 2026, 5:12 PM EST
Price at Filing:
$53.57
Real-time Price:
$55.72
Change:
+$2.15 (+4%)
Market Cap:
$8.768B
PCVX
Jan 29, 2026, 4:01 PM EST
Price at Filing:
$52.82
Real-time Price:
$55.72
Change:
+$2.90 (+5%)
Market Cap:
$8.768B